ID   UKRV-Mel-14a
AC   CVCL_A710
DR   cancercelllines; CVCL_A710
DR   Cosmic; 2163822
DR   ESTDAB; ESTDAB-110
DR   Wikidata; Q54990571
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala148Thr (c.442G>A); ClinVar=VCV000041580; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu326fs (c.976insGA); Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-110
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   FGA: 25
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A711 ! UKRV-Mel-14b
OI   CVCL_C409 ! UKRV-Mel-14c
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
RX   PubMed=19340423; DOI=10.1007/s00262-009-0701-z; PMCID=PMC11030131;
RA   Mendez R., Aptsiauri N., Del Campo A., Maleno I., Cabrera T.,
RA   Ruiz-Cabello Osuna F., Garrido F., Garcia-Lora A.;
RT   "HLA and melanoma: multiple alterations in HLA class I and II
RT   expression in human melanoma cell lines from ESTDAB cell bank.";
RL   Cancer Immunol. Immunother. 58:1507-1515(2009).
//
RX   PubMed=23851445; DOI=10.1158/1541-7786.MCR-13-0006;
RA   Dahl C., Christensen C., Jonsson G., Lorentzen A., Skjodt M.L.,
RA   Borg A., Pawelec G., Guldberg P.;
RT   "Mutual exclusivity analysis of genetic and epigenetic drivers in
RT   melanoma identifies a link between p14 ARF and RARbeta signaling.";
RL   Mol. Cancer Res. 11:1166-1178(2013).
//